Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
34 hedge funds and large institutions have $102M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
13% more funds holding
Funds holding: 30 → 34 (+4)
2% less capital invested
Capital invested by funds: $105M → $102M (-$2.35M)
70% less call options, than puts
Call options by funds: $75K | Put options by funds: $251K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$5.16M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$1.29M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$1.24M |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$131K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.22M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.58M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$345K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$150K |
| 5 |
Morgan Stanley
New York
|
-$135K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $4K | -$7.3K | -876 | -62% |
|
|
MFS
27
MSI Financial Services
Springfield,
Massachusetts
| $2K | +$1.67K | +200 | New |
|
|
CLOS
28
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $1K | – | – | – |
|
29
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
30
Adage Capital Partners
Boston,
Massachusetts
| – | -$4.22M | -500,000 | Closed |
|
|
31
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$345K | -41,420 | Closed |
|
32
Bank of America
Charlotte,
North Carolina
| – | -$6.09K | -731 | -94% |
|
33
Citigroup
New York
| – | -$83 | -10 | -50% |
|
34
JP Morgan Chase
New York
| – | +$17 | +2 | New |
|
35
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$409 | +49 | New |
|
CORV Hedge Fund Activity: Q4 2015 in Review
34 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q4 2015, worth a combined $102M — down 2.2% from $105M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CORV positions and 2 closed out — a net gain of 4 holders — while 12 added to existing stakes and 9 trimmed.
The largest buyer was Westfield Capital Management, adding an estimated $5.16M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $4.22M sold.
- 34 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q4 2015, up from 30 in Q3 2015.
- Funds reported $102M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q4 2015, down 2.2% quarter-over-quarter.
- 6 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q4 2015 and 2 closed out, a net change of +4 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q4 2015 was Westfield Capital Management, an estimated $5.16M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q4 2015 was Adage Capital Partners, an estimated $4.22M sold.
Based on aggregated 13F filings for Q4 2015.